Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 42Unknown 19Terminated 10Recruiting 6Active not recruiting 3Withdrawn 2No longer available 1Enrolling by invitation 1Approved for marketing 1

Sponsor Class

OTHER 6NIH 1INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 6

Conditions

Breast Neoplasms 1397Neoplasms 1129Prostatic Neoplasms 744Lung Neoplasms 619Colorectal Neoplasms 596Carcinoma, Non-Small-Cell Lung 569Carcinoma, Hepatocellular 413Pancreatic Neoplasms 402Leukemia, Myeloid, Acute 398Stomach Neoplasms 355Multiple Myeloma 326Brain Neoplasms 311Ovarian Neoplasms 309Head and Neck Neoplasms 289Neoplasm Metastasis 273Precursor Cell Lymphoblastic Leukemia-Lymphoma 260Rectal Neoplasms 253Uterine Cervical Neoplasms 248Recurrence 248Melanoma 242Esophageal Neoplasms 237Glioblastoma 232Squamous Cell Carcinoma of Head and Neck 231Lymphoma 213Sarcoma 207Urinary Bladder Neoplasms 192Colonic Neoplasms 192Glioma 191Triple Negative Breast Neoplasms 188Hematologic Neoplasms 183

Interventions

Tretinoin 2Gemtuzumab 2Arsenic Trioxide 2arsenous acid 1Magnetic Resonance Spectroscopy 1Gadolinium 1Fluorodeoxyglucose F18 1Arsenic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × OTHER × Leukemia, Promyelocytic, Acute × Clear all
NCT01409161 2026-05-20

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

M.D. Anderson Cancer Center

Phase 2 Recruiting
151 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT02390635 2026-04-17

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

M.D. Anderson Cancer Center

Phase 1 Recruiting
77 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute

NCT04687176 2025-06-12

Frontline Oral Arsenic Trioxide for APL

The University of Hong Kong

Phase 2 Recruiting
100 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT06982274 2025-05-30

IC-APL2020

Instituto do Cancer do Estado de São Paulo

Phase 2 Recruiting
115 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT04793919 2024-04-15

Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia

Associazione Italiana Ematologia Oncologia Pediatrica

Phase 2 Recruiting
89 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT04897490 2024-01-09

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Grupo Argentino de Tratamiento de la Leucemia Aguda

Recruiting
50 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡